Our results provide evidence that the LDL-/HDL-cholesterol ratio and the E-selectin level in serum as a marker for vascular wall inflammation were raised in IDM/NIDDM patients compared to CTR with CAD. This evidence concerns the gene SELE and type 2 diabetes mellitus.